Cell Free Regenerative Extracellular Vesicle Therapy for Ocular Diseases

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Cell Biology

Background:

• Traditional stem cell therapies for ocular diseases face challenges.
• Extracellular vesicles (EVs) offer a cell-free alternative with therapeutic potential.
• EVs derived from various stem and ocular cells are being investigated.

Purpose of the Study:

• To evaluate the therapeutic potential of stem cell-derived extracellular vesicles (EVs) for ocular diseases.
• To explore EVs as a cell-free alternative to traditional stem cell therapies.
• To review preclinical evidence and ongoing clinical trials of EVs in ophthalmology.

Main Methods:

• Comprehensive literature review of preclinical studies on EVs from various stem cells (MSCs, iPSCs, ESCs) and ocular cells.
• Data extraction on EV origin, isolation, administration, disease models, outcomes, and mechanisms.
• Evaluation of registered clinical trials for ocular EV therapies.

Main Results:

• EVs demonstrated regenerative and immunomodulatory effects in conditions like dry eye, uveitis, glaucoma, and retinal degenerations.
• Diverse cell sources, including MSCs, iPSCs, and ocular-resident cells, are used for EV production.
• Bioengineered EVs and mechanisms like miRNA regulation, immune modulation, and oxidative stress reduction were reported.
• Early-phase clinical trials are underway for ocular EV therapies.

Conclusions:

• Stem cell-derived EVs are a promising cell-free regenerative therapy for ocular diseases.
• Clinical translation requires optimized EV source selection, scalable production, and regulatory alignment.
• Further research into disease-specific mechanisms and cargo characterization is crucial for successful translation.